Lonza
Lonza
LONN
SIX
555.60
CHF
-3.64%
About
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications.
The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms.
The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 149.2K |
| Three Month Average Volume | 3.5M |
| High Low | |
| Fifty-Two Week High | 589.4 CHF |
| Fifty-Two Week Low | 308.6 CHF |
| Fifty-Two Week High Date | 29 Jul 2024 |
| Fifty-Two Week Low Date | 26 Oct 2023 |
| Price and Volume | |
| Current Price | 555.6 CHF |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | -4.99% |
| Thirteen Week Relative Price Change | 10.22% |
| Twenty-Six Week Relative Price Change | 10.28% |
| Fifty-Two Week Relative Price Change | 1.67% |
| Year-to-Date Relative Price Change | 40.68% |
| Price Change | |
| One Day Price Change | 0.14% |
| Thirteen Week Price Change | 14.23% |
| Twenty-Six Week Price Change | 19.33% |
| Five Day Price Change | -0.68% |
| Fifty-Two Week Price Change | 13.64% |
| Year-to-Date Price Change | 57.08% |
| Month-to-Date Price Change | -5.41% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 131.0655 CHF |
| Book Value Per Share (Most Recent Quarter) | 133.8266 CHF |
| Tangible Book Value Per Share (Last Fiscal Year) | 65.33864 CHF |
| Tangible Book Value Per Share (Most Recent Quarter) | 64.373 CHF |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 14.33043 CHF |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 91.15976 CHF |
| Revenue Per Share (Trailing Twelve Months) | 92.53282 CHF |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | 4 CHF |
| Dividend Per Share (Trailing Twelve Months) | 4 CHF |
| Dividend Per Share (5 Year) | 3.25 CHF |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | 8.87576 CHF |
| Excluding Extraordinary Items (Trailing Twelve Months) | 7.93604 CHF |
| Normalized (Last Fiscal Year) | 14.40065 CHF |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | 8.88219 CHF |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | 7.94089 CHF |
| Including Extraordinary Items (Last Fiscal Year) | 8.87576 CHF |
| Including Extraordinary Items (Trailing Twelve Months) | 7.93604 CHF |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 23.12921 CHF |
| Cash Per Share (Most Recent Quarter) | 28.86624 CHF |
| Cash Flow Per Share (Last Fiscal Year) | 17.31723 CHF |
| Cash Flow Per Share (Trailing Twelve Months) | 15.72616 CHF |
| Free Cash Flow Per Share (Trailing Twelve Months) | -4.62941 CHF |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -8 |
| Cash Flow Revenue (Trailing Twelve Months) | -5 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | 10.44% |
| Pretax Margin (Last Fiscal Year) | 11.76% |
| Pretax Margin (5 Year) | 16.70% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 35.82% |
| Gross Margin (Trailing Twelve Months) | 29.21% |
| Gross Margin (5 Year) | 39.15% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | 13.10% |
| Operating Margin (Trailing Twelve Months) | 13.05% |
| Operating Margin (5 Year) | 18.47% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | 9.75% |
| Net Profit Margin (Trailing Twelve Months) | 8.57% |
| Net Profit Margin (5 Year) | 14.52% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | 9.31% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | -0.68% |
| Revenue Growth (3 Year) | 3.92% |
| Revenue Change (Trailing Twelve Months) | 5.97% |
| Revenue Per Share Growth | 4.21% |
| Revenue Growth (5 Year) | 14.22% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | 23.95% |
| Total Debt (5 Year) | -5.07% |
| Dividends | |
| Dividend Growth (3 Year) | 10.06% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -16.79% |
| EPS Change (Trailing Twelve Months) | -47.86% |
| EPS Growth (3 Year) | 0.25% |
| EPS Growth (5 Year) | -3.15% |
| EBITDA | |
| EBITDA (5 Year) | 5.74% |
| EBITDA (5 Year Interim) | 1.24% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -3.89% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 9 |
| Price to Tangible Book (Most Recent Quarter) | 9 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 1.8B |
| Net Debt (Last Fiscal Year) | 1.5B |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 6 |
| Price to Sales (Trailing Twelve Months) | 6 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | 70 |
| PE Normalized (Last Fiscal Year) | 39 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 62 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 95 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 28 |
| PE Including Extraordinary Items (Trailing Twelve Months) | 70 |
| Dividends | |
| Dividend Yield (5 Year) | 0.65% |
| Dividend Yield | 0.72% |
| Current Dividend Yield | 0.72% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 4 |
| Price to Book (Most Recent Quarter) | 4 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 31 |
| Long Term Debt to Equity (Most Recent Quarter) | 39 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | 44.11% |
| Payout Ratio (Trailing Twelve Months) | 50.34% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 1 |
| Quick Ratio (Most Recent Quarter) | 1 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 2 |
| Current Ratio (Most Recent Quarter) | 2 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -554,000,000 |
| Free Cash Flow (Trailing Twelve Months) | -335,000,000 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | 16 |
| Net Interest Coverage (Trailing Twelve Months) | 5 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 33 |
| Total Debt to Equity (Most Recent Quarter) | 41 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | 3.83% |
| Return on Assets (Trailing Twelve Months) | 3.23% |
| Return on Assets (5 Year) | 5.07% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | 6.52% |
| Return on Equity (Trailing Twelve Months) | 5.83% |
| Return on Equity (5 Year) | 9.45% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | 4.64% |
| Return on Investment (Trailing Twelve Months) | 3.81% |
| Return on Investment (5 Year) | 6.21% |